SCHEMBL14366456

SCHEMBL14366456

CO[C@@H](Cc1cccc(C#CCCCOc2ccc(Oc3ccccc3)cc2)c1)C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.79
PPARA Q07869 17/20 0.79
PPARD Q03181 10/20 0.79
ALOX5 P09917 1/20 0.40
FFAR1 O14842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380022 1.00 PPARG (0.79) PPARGPPARAPPARDALOX5FFAR1
SCHEMBL5380637 0.92 PPARG (0.67) PPARGPPARAPPARDALOX5
SCHEMBL5400562 0.89 PPARG (1.00) PPARGPPARAPPARDFFAR1
SCHEMBL5381218 0.89 PPARG (1.00) PPARGPPARAPPARDFFAR1
SCHEMBL14366461 0.88 PPARG (0.62) PPARGPPARAPPARDALOX5
SCHEMBL5381121 0.85 PPARG (0.94) PPARGPPARAPPARDFFAR1
SCHEMBL5390838 0.85 PPARG (0.94) PPARGPPARAPPARDFFAR1
SCHEMBL14366451 0.85 PPARG (0.81) PPARGPPARAPPARD
SCHEMBL5384053 0.85 PPARG (0.81) PPARGPPARAPPARD
SCHEMBL22607960 0.84 PPARA (0.91) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors PPARG, NCOA4, PPARA PPARG 1/4885PPARA 3/4885PPARD 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.